IL17A and myasthenia gravis: In MG, the abnormal thymic epithelial cells (TECs) could secrete IL-23, leading to the activation of Th17 cells and subsequently promoting the release of another pro-inflammatory cytokine IL-17 (Villegas et al., 2019).